These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32706185)

  • 41. Synergic control of action in levodopa-naïve Parkinson's disease patients: I. Multi-finger interaction and coordination.
    de Freitas PB; Freitas SMSF; Reschechtko S; Corson T; Lewis MM; Huang X; Latash ML
    Exp Brain Res; 2020 Jan; 238(1):229-245. PubMed ID: 31838566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levodopa and subthalamic deep brain stimulation responses are not congruent.
    Zaidel A; Bergman H; Ritov Y; Israel Z
    Mov Disord; 2010 Oct; 25(14):2379-86. PubMed ID: 20824733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive Factors of Antiparkinsonian Drug Reduction after Subthalamic Stimulation for Parkinson's Disease.
    Samura K; Miyagi Y; Kawaguchi M; Yoshida F; Okamoto T; Kawashima M
    Neurol Med Chir (Tokyo); 2019 Sep; 59(9):331-336. PubMed ID: 31231086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unilateral Subthalamic Nucleus Stimulation in the Treatment of Asymmetric Parkinson"s Disease with Early Motor Complications.
    Sobstyl M; Zabek M; Zaczynski A; Gorecki W; Mossakowski Z; Brzuszkiewicz-Kuzmicka G
    Turk Neurosurg; 2017; 27(2):294-300. PubMed ID: 27593744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potentiation of response to low doses of levodopa in MPTP-injected monkeys by chemical unilateral subthalamotomy.
    Jourdain VA; Grégoire L; Morissette M; Morin N; Parent M; Di Paolo T
    J Neurosurg; 2013 Jan; 118(1):180-91. PubMed ID: 23082890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gait analysis in patients with advanced Parkinson disease: different or additive effects on gait induced by levodopa and chronic STN stimulation.
    Lubik S; Fogel W; Tronnier V; Krause M; König J; Jost WH
    J Neural Transm (Vienna); 2006 Feb; 113(2):163-73. PubMed ID: 15959852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients.
    Tir M; Devos D; Blond S; Touzet G; Reyns N; Duhamel A; Cottencin O; Dujardin K; Cassim F; Destée A; Defebvre L; Krystkowiak P
    Neurosurgery; 2007 Aug; 61(2):297-304; discussion 304-5. PubMed ID: 17762742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Lanotte M; Lopiano L
    Mov Disord; 2011 Mar; 26(4):664-70. PubMed ID: 21469197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive timing functions of cortical beta oscillations are impaired in Parkinson's disease and influenced by L-DOPA and deep brain stimulation of the subthalamic nucleus.
    Gulberti A; Moll CK; Hamel W; Buhmann C; Koeppen JA; Boelmans K; Zittel S; Gerloff C; Westphal M; Schneider TR; Engel AK
    Neuroimage Clin; 2015; 9():436-49. PubMed ID: 26594626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions between deep brain stimulation and levodopa in Parkinson's disease.
    Nutt JG; Rufener SL; Carter JH; Anderson VC; Pahwa R; Hammerstad JP; Burchiel KJ
    Neurology; 2001 Nov; 57(10):1835-42. PubMed ID: 11723273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrophysiological registration of phonological perception in the subthalamic nucleus of patients with Parkinson's Disease.
    De Letter M; Aerts A; Van Borsel J; Vanhoutte S; De Taeye L; Raedt R; van Mierlo P; Boon P; Van Roost D; Santens P
    Brain Lang; 2014 Nov; 138():19-26. PubMed ID: 25265552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subthalamic deep brain stimulation improves auditory sensory gating deficit in Parkinson's disease.
    Gulberti A; Hamel W; Buhmann C; Boelmans K; Zittel S; Gerloff C; Westphal M; Engel AK; Schneider TR; Moll CK
    Clin Neurophysiol; 2015 Mar; 126(3):565-74. PubMed ID: 25085452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease.
    Kedia S; Moro E; Tagliati M; Lang AE; Kumar R
    Neurology; 2004 Dec; 63(12):2410-2. PubMed ID: 15623715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of the nicotinic acetylcholine receptor agonist SIB-1508Y on object retrieval performance in MPTP-treated monkeys: comparison with levodopa treatment.
    Schneider JS; Van Velson M; Menzaghi F; Lloyd GK
    Ann Neurol; 1998 Mar; 43(3):311-7. PubMed ID: 9506547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
    Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
    Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deep brain stimulation effects on gait variability in Parkinson's disease.
    Hausdorff JM; Gruendlinger L; Scollins L; O'Herron S; Tarsy D
    Mov Disord; 2009 Aug; 24(11):1688-92. PubMed ID: 19554569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
    J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.
    Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A
    Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.